Tivic Health Systems Inc.

AI Score

XX

Unlock

3.61
-1.14 (-24.00%)
At close: Apr 08, 2025, 3:59 PM
3.32
-8.03%
Pre-market: Apr 09, 2025, 07:22 AM EDT

Company Description

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions.

Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation.

The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com.

Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Tivic Health Systems Inc.
Tivic Health Systems Inc. logo
Country United States
IPO Date Nov 11, 2021
Industry Medical - Devices
Sector Healthcare
Employees 7
CEO Jennifer Ernst

Contact Details

Address:
25821 Industrial Boulevard
Hayward, California
United States
Website https://www.tivichealth.com

Stock Details

Ticker Symbol TIVC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001787740
CUSIP Number 888705100
ISIN Number US8887052095
Employer ID 81-4016391
SIC Code 3845

Key Executives

Name Position
Jennifer Ernst Co-Founder, Chief Executive Officer & Director
Lisa G. Wolf Interim Chief Financial Officer
Michael Kevin Handley Chief Operating Officer & President of Tivic Biopharma
Dr. Blake Gurfein Ph.D. Chief Scientific Officer

Latest SEC Filings

Date Type Title
Apr 03, 2025 8-K Current Report
Mar 21, 2025 10-K Annual Report
Mar 21, 2025 8-K Current Report
Mar 06, 2025 8-K Current Report
Mar 05, 2025 8-K Current Report
Feb 24, 2025 4 Filing
Feb 24, 2025 3 Filing
Feb 24, 2025 8-K Current Report
Feb 12, 2025 8-K Current Report
Feb 05, 2025 8-K Current Report